美股異動｜吉利德科學盤前漲超4% Q4業績及今年盈利指引超預期

新浪財經

02-12

格隆匯2月12日｜吉利德科學(GILD.US)盤前漲超4%，報100.03美元，接近歷史高位水平。消息面上，吉利德科學公佈去年第四季度業績，營收同比增長6%至75.69億美元，高於市場預期的71.4美元；其中，艾滋病藥銷售額同比增長16%至55億美元。純利同比增長25%至17.83億美元；調整後每股收益爲1.9美元，高於市場預期的1.7美元。

指引方面，該公司預計今年銷售額介乎282億至286億美元，市場預期爲284.2億美元；調整後每股盈利7.7至8.1美元，市場預期爲7.58美元。

海量資訊、精準解讀，盡在新浪財經APP

責任編輯：郭明煜

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2510234223"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2510234223\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2510234223?lang=zh_TW&edition=fundamental","thumbnail":"http://n.sinaimg.cn/spider20250212/640/w351h289/20250212/dc55-0f5d9c93364822a05710b25e1c397e97.jpg","is_english":false,"pubTime":"2025-02-12 17:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2510234223","market":"us","top_or_hot":-1,"title":"美股異動｜吉利德科學盤前漲超4% Q4業績及今年盈利指引超預期","media":"新浪財經","content":"<html><body><div>\n<p cms-style=\"font-L \">格隆匯2月12日｜<span><a href=\"https://laohu8.com/S/GILD\">吉利德科學</a></span><span></span>(GILD.US)盤前漲超4%，報100.03美元，接近歷史高位水平。消息面上，吉利德科學公佈去年第四季度業績，營收同比增長6%至75.69億美元，高於市場預期的71.4美元；其中，艾滋病藥銷售額同比增長16%至55億美元。純利同比增長25%至17.83億美元；調整後每股收益爲1.9美元，高於市場預期的1.7美元。</p>\n<p cms-style=\"font-L\">指引方面，該公司預計今年銷售額介乎282億至286億美元，市場預期爲284.2億美元；調整後每股盈利7.7至8.1美元，市場預期爲7.58美元。</p>\n<div><img src=\"http://n.sinaimg.cn/spider20250212/640/w351h289/20250212/dc55-0f5d9c93364822a05710b25e1c397e97.jpg\"/><span></span></div>\n<div></div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量資訊、精準解讀，盡在新浪財經APP</div>\n</div>\n<p>責任編輯：郭明煜 </p>\n</div></body></html>","source":"sina_us","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>美股異動｜吉利德科學盤前漲超4% Q4業績及今年盈利指引超預期</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股異動｜吉利德科學盤前漲超4% Q4業績及今年盈利指引超預期\n</h2>\n<h4 class=\"meta\">\n</h4><p class=\"head\">\n<strong class=\"h-name small\">新浪財經</strong><span class=\"h-time small\">2025-02-12 17:11</span>\n</p>\n</header>\n<article>\n<div>\n<p cms-style=\"font-L \">格隆匯2月12日｜<span><a href=\"https://laohu8.com/S/GILD\">吉利德科學</a></span><span></span>(GILD.US)盤前漲超4%，報100.03美元，接近歷史高位水平。消息面上，吉利德科學公佈去年第四季度業績，營收同比增長6%至75.69億美元，高於市場預期的71.4美元；其中，艾滋病藥銷售額同比增長16%至55億美元。純利同比增長25%至17.83億美元；調整後每股收益爲1.9美元，高於市場預期的1.7美元。</p>\n<p cms-style=\"font-L\">指引方面，該公司預計今年銷售額介乎282億至286億美元，市場預期爲284.2億美元；調整後每股盈利7.7至8.1美元，市場預期爲7.58美元。</p>\n<div><img src=\"http://n.sinaimg.cn/spider20250212/640/w351h289/20250212/dc55-0f5d9c93364822a05710b25e1c397e97.jpg\"/><span></span></div>\n<div></div>\n<div>\n<div><img src=\"\"/></div>\n<div>海量資訊、精準解讀，盡在新浪財經APP</div>\n</div>\n<p>責任編輯：郭明煜 </p>\n</div>\n<div class=\"bt-text\">\n<p> 來源：<a href=\"https://finance.sina.com.cn/stock/bxjj/2025-02-12/doc-inekfnme9307558.shtml\">新浪財經</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2089984988.USD","symbol_name":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","start_time":0,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-02-12/doc-inekfnme9307558.shtml","article_id":"2510234223","we_media_id":null,"thumbnails":["http://n.sinaimg.cn/spider20250212/640/w351h289/20250212/dc55-0f5d9c93364822a05710b25e1c397e97.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2510234223","pubTimestamp":1739351514,"columns":[],"sourceInfo":{"source_id":"sina_us","name":"新浪美股"},"weMediaInfo":null,"summary":"格隆匯2月12日｜吉利德科學(GILD.US)盤前漲超4%，報100.03美元，接近歷史高位水平。消息面上，吉利德科學公佈去年第四季度業績，營收同比增長6%至75.69億美元，高於市場預期的71.4美元；其中，艾滋病藥銷售額同比增長16%至55億美元。純利同比增長25%至17.83億美元；調整後每股收益為1.9美元，高於市場預期的1.7美元。\n指引方面，該公司預計今年銷售額介乎282億至286億美元，市場預期為284.2億美元；調整後每股盈利7.7至8.1美元，市場預期為7.58美元。\n\n\n\n\n海量資訊、精準解讀，盡在新浪財經APP\n\n責任編輯：郭明煜","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","BK4578":"CAR-T","LU1839511570.USD":"WELLS FARGO GLOBAL FACTOR ENHANCED EQUITY \"I\" (USD) ACC","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","GILD":"吉利德科学","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","BK4588":"碎股","BK4568":"美国抗疫概念","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","BK4550":"红杉资本持仓","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU2087621335.USD":"ALLSPRING GLOBAL FACTOR ENHANCED EQUITY \"A\" (USD) ACC","BK4583":"猴痘概念","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","BK4532":"文艺复兴科技持仓","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","BK4585":"ETF&股票定投概念","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","BK4139":"生物科技","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","BK4566":"资本集团"},"translate_title":"Changes in U.S. stocks | Gilead Sciences rose more than 4% before the market Q4 Results and this year's earnings guidance exceed expectations","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GILD":1},"content_text":"格隆匯2月12日｜吉利德科學(GILD.US)盤前漲超4%，報100.03美元，接近歷史高位水平。消息面上，吉利德科學公佈去年第四季度業績，營收同比增長6%至75.69億美元，高於市場預期的71.4美元；其中，艾滋病藥銷售額同比增長16%至55億美元。純利同比增長25%至17.83億美元；調整後每股收益為1.9美元，高於市場預期的1.7美元。\n指引方面，該公司預計今年銷售額介乎282億至286億美元，市場預期為284.2億美元；調整後每股盈利7.7至8.1美元，市場預期為7.58美元。\n\n\n\n\n海量資訊、精準解讀，盡在新浪財經APP\n\n責任編輯：郭明煜","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0}}}